An international randomised trial found fewer cases of acute kidney injury with cefazolin than with flucloxacillin or cloxacillin, while meeting its survival noninferiority threshold.
A Novartis oral pill for relapsing multiple sclerosis outperformed standard therapy in two large Phase III trials, and unlike a rival BTK inhibitor the FDA declined over liver concerns, it showed no liver safety signal. Here is what the REMODEL
The Spanish pharmaceutical company PharmaMar said on Tuesday that a paper had been published in the journal Science confirming that its drug Plitidepsin possessed “strong preclinical efficacy” in treating coronavirus. Shortly after
Russia signed a contract with Bolivia for the supply of Sputnik V vaccine against COVID-19 coronavirus infection. This was announced by the President of the South American Republic Luis Arce. According to
The corona vaccine from the Mainz-based company Biontech and its US partner Pfizer is in use. It has been extensively tested and the data from the test series are promising. What is
Recent media reported in India that weeks after first vaccine dose during the trial, a Minister got Covid-19. It may have hogged the headline in regard to India’s Covaxin produced by Bharat
The Government continues to strive to position itself in the face of what will be the demand for vaccines against the coronavirus, when the efficacy and safety of some of those currently
Faced with the current coronavirus pandemic, more than 160 vaccines are being developed against SARS-CoV-2 around the world, hoping to bring one to market in record time to ease the global crisis.
The tests carried out by the Johnson & Johnson Pharmaceutical about the vaccine covid-19 have been suspended due to an unexplained illness that one of the participants presented. Initially, the news was
The Russian Direct Investment Fund hopes that one of the new coronavirus vaccines developed in that country will be registered within 10 days, according to the head of the fund, Kirill Dmítriyev.
The director-general of the World Health Organization (WHO), Tedros Adhanom Ghebreyesus, stated that, despite the progress that has been made in recent weeks in the development of a vaccine against Covid-19, the
Follow